Sihuan Pharmaceutical Co., Ltd. recently announced that the company has a risk of suspension of listing. It said that in view of the company’s two consecutive years of losses in 2005 and 2006, the company’s stock trading has been delisted by the Shenzhen Stock Exchange since April 27, 2007. Risk warning. As of September 31, 2007, the company's net profit was RMB -18,903,784.02. If the company could not turn losses into profit on December 31, 2007, according to the relevant provisions of the Shenzhen Stock Exchange Listing Rules, Shenzhen Securities The Exchange will suspend the listing of the company's shares from the date of the company's 2007 annual report disclosure, and the company's stock will be suspended.
Sihuan Pharmaceutical said that the company is currently undergoing a major restructuring. The company and the reorganization party are actively negotiating with creditors through negotiations. They hope that the creditors will be exempted from corporate debts and strive to achieve the company's 2007 losses, thus avoiding suspension of listing risks, but debt. Whether the restructuring can be successful and whether it can be included in the 2007 profit and loss by December 31, 2007 depends on the attitude of the creditor and the progress of the company's negotiations with the creditors. The matter is still uncertain.
According to the announcement, excluding debt restructuring and other non-recurring gains and losses, according to preliminary estimates by the company's financial department, it is estimated that the company's net profit for 2007 may be about -50 million yuan.
2.CE, FDA ,NSF and ISO approval
Sihuan Pharmaceutical said that the company is currently undergoing a major restructuring. The company and the reorganization party are actively negotiating with creditors through negotiations. They hope that the creditors will be exempted from corporate debts and strive to achieve the company's 2007 losses, thus avoiding suspension of listing risks, but debt. Whether the restructuring can be successful and whether it can be included in the 2007 profit and loss by December 31, 2007 depends on the attitude of the creditor and the progress of the company's negotiations with the creditors. The matter is still uncertain.
According to the announcement, excluding debt restructuring and other non-recurring gains and losses, according to preliminary estimates by the company's financial department, it is estimated that the company's net profit for 2007 may be about -50 million yuan.
1. Powder or powder free
2.CE, FDA ,NSF and ISO approval
3. AQL1.5/4.0,Medical grade and Industrial ,Food grade etc.
4.colour:Transparent or nature , blue, white ,yellow available colors
5. Tasteless, harmless, nontoxic, alkali-resistant, acid-resistant.
6. Suitable in the fields of Industrial electronic factory, medical examination,hotel, restaurant, food process, etc.
7.Free latex protein ,no skin innitation
8.Soft and comfortable.
9.Ambidextrous, single use only.
10.Beaded cuff.
11.Size: S,M,L,XL XXL
12.Vinyl,free DOP/DEHP
Vinyl Gloves,Disposable Vinyl Gloves,Medical Gloves,Examination Gloves
Zibo Hongye Shangqin Medical Science and Technology Co.,Ltd. , https://www.vinylgloves.cn